The Effects of COVID-19 on Non-Communicable Disease

iMMAP Inc.
Bangladesh, Burkina Faso, Colombia, Democratic Republic of the Congo, Nigeria, Syria
December 16, 2021
Case Study

Executive Summary

Non-Communicable Diseases (NCDs) are health conditions that cannot be transmitted from onepatient to another, and usually manifest a prolonged, persistent, and slow pathology. NCDs areresponsible for over 70% of all deaths, with nearly 80% of these deaths occurring in low-andmiddle-income countries. In addition, NCDs constitute approximately 80% of all years lived withdisability globally. With the global population aging, rises in multi-morbidity, longer lifeexpectancies, and increasing survival rates, more and more people are expected to live with thehealth burden of NCDs (WHO, 2020).COVID-19 is an ongoing pandemic that emerged at the end of 2019 in China and spread quickly tothe rest of the world, affecting, both directly and indirectly, the health and life of the globalpopulation. This research attempts to understand the effects of the COVID-19 pandemic on NCDsin Burkina Faso, Bangladesh, Colombia, DRC, Nigeria, and Syria. All six countries are included in theiMMAP COVID-19 Situational Analysis Program, as they are affected by humanitarian crises andconflicts. The report covers the effects of COVID-19 on access to health services, resourcesallocations, and the medical status of the patients with NCDs.The research relies on the data collected from trusted academic and institutional sources stored inthe DEEP Platform, or directly from World Health Organization (WHO), Centre for Disease Control(CDC), British Medical Journal (BMJ), and ELSEVIER. This secondary data review wascomplemented with primary data, collected through a key informants’ survey conducted usingKobo Toolbox.

Report PDF